Renaissance Technologies's ALXO Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 164.5K shares of ALX Oncology Holdings Inc. (ALXO) worth $301,033, representing 0.00% of the portfolio. First purchased in 2021-Q4, this medium-term investment has been held for 16 quarters.
Based on 13F filings, Renaissance Technologies has maintained a strategic position in ALXO, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2024, adding 204.1K shares. Largest reduction occurred in Q3 2024, reducing 282.9K shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's ALX Oncology Holdings (ALXO) Holding Value Over Time
Track share changes against reported price movement
Quarterly ALX Oncology Holdings (ALXO) Trades by Renaissance Technologies
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2021 | +167,900 | New Buy | 167,900 | $21.49 |
| Q1 2022 | -19,100 | Reduce 11.38% | 148,800 | $16.90 |
| Q2 2022 | +78,883 | Add 53.01% | 227,683 | $8.09 |
| Q3 2022 | -57,083 | Reduce 25.07% | 170,600 | $9.57 |
| Q4 2022 | -74,800 | Reduce 43.85% | 95,800 | $0.01 |
| Q1 2023 | +31,019 | Add 32.38% | 126,819 | $0.00 |
| Q2 2023 | +55,981 | Add 44.14% | 182,800 | $0.01 |
| Q3 2023 | +29,700 | Add 16.25% | 212,500 | $4.80 |
| Q4 2023 | +58,000 | Add 27.29% | 270,500 | $14.89 |
| Q1 2024 | -36,400 | Reduce 13.46% | 234,100 | $11.15 |
| Q2 2024 | +204,100 | Add 87.18% | 438,200 | $6.03 |
| Q3 2024 | -282,900 | Reduce 64.56% | 155,300 | $1.82 |
| Q4 2024 | -155,300 | Sold Out | 155,300 | $0.00 |
| Q1 2025 | +14,299 | New Buy | 14,299 | $0.62 |
| Q2 2025 | +71,100 | Add 497.24% | 85,399 | $0.42 |
| Q3 2025 | +79,100 | Add 92.62% | 164,499 | $1.83 |
Renaissance Technologies's ALX Oncology Holdings Investment FAQs
Renaissance Technologies first purchased ALX Oncology Holdings Inc. (ALXO) in Q4 2021, acquiring 167,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held ALX Oncology Holdings Inc. (ALXO) for 16 quarters since Q4 2021. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's largest addition to ALX Oncology Holdings Inc. (ALXO) was in Q2 2024, adding 438,200 shares worth $2.64 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 164,499 shares of ALX Oncology Holdings Inc. (ALXO), valued at approximately $301,033. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, ALX Oncology Holdings Inc. (ALXO) represents approximately 0.00% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's peak holding in ALX Oncology Holdings Inc. (ALXO) was 438,200 shares, as reported at the end of Q2 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.